相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, That Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy
Po C. Chen et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of Spinal Muscular Atrophy
Jacqueline J. Glascock et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
Melissa Bowerman et al.
BMC MEDICINE (2012)
New Therapeutic Approaches to Spinal Muscular Atrophy
Aga Lewelt et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
Decreasing Disease Severity in Symptomatic, Smn-/-; SMN2+/+, Spinal Muscular Atrophy Mice Following scAAV9-SMN Delivery
Jacqueline J. Glascock et al.
HUMAN GENE THERAPY (2012)
Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
Lluis Samaranch et al.
HUMAN GENE THERAPY (2012)
A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
Paul N. Porensky et al.
HUMAN MOLECULAR GENETICS (2012)
Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy
Karen K. Y. Ling et al.
HUMAN MOLECULAR GENETICS (2012)
Histone deacetylase inhibition suppresses myogenin-dependent atrogene activation in spinal muscular atrophy mice
Katherine V. Bricceno et al.
HUMAN MOLECULAR GENETICS (2012)
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects
Eugenio Fernandez Alanis et al.
HUMAN MOLECULAR GENETICS (2012)
Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy
Monir Shababi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Optimization of SMN Trans-Splicing Through the Analysis of SMN Introns
Monir Shababi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
A Role for SMN Exon 7 Splicing in the Selective Vulnerability of Motor Neurons in Spinal Muscular Atrophy
Matteo Ruggiu et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular Atrophy
Erkan Y. Osman et al.
MOLECULAR THERAPY (2012)
The AAV Vector Toolkit: Poised at the Clinical Crossroads
Aravind Asokan et al.
MOLECULAR THERAPY (2012)
Epigenetic protein families: a new frontier for drug discovery
Cheryl H. Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice
Li-Kai Tsai et al.
NEUROBIOLOGY OF DISEASE (2012)
Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy
E. Somers et al.
NEUROMUSCULAR DISORDERS (2012)
Restricted Morphological and Behavioral Abnormalities following Ablation of β-Actin in the Brain
Thomas R. Cheever et al.
PLOS ONE (2012)
Identification of Novel Compounds That Increase SMN Protein Levels Using an Improved SMN2 Reporter Cell Assay
Jonathan J. Cherry et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US Hutterites
Jessica X. Chong et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms
Monica Nizzardo et al.
EXPERIMENTAL NEUROLOGY (2011)
Impaired minor tri-snRNP assembly generates differential splicing defects of U12-type introns in lymphoblasts derived from a type I SMA patient
Nawal Boulisfane et al.
HUMAN MOLECULAR GENETICS (2011)
Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
Elisa Dominguez et al.
HUMAN MOLECULAR GENETICS (2011)
HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects
Lisa Hubers et al.
HUMAN MOLECULAR GENETICS (2011)
Increased IGF-1 in muscle modulates the phenotype of severe SMA mice
Marta Bosch-Marce et al.
HUMAN MOLECULAR GENETICS (2011)
The COPI vesicle complex binds and moves with survival motor neuron within axons
Cyril Jayakumar Peter et al.
HUMAN MOLECULAR GENETICS (2011)
Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice
Deborah Y. Kwon et al.
HUMAN MOLECULAR GENETICS (2011)
Temporal requirement for high SMN expression in SMA mice
Thanh T. Le et al.
HUMAN MOLECULAR GENETICS (2011)
Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway
Faraz Farooq et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Discovery, Synthesis, and Biological Evaluation of Novel SMN Protein Modulators
Jingbo Xiao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid
Sanne Piepers et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
The Survival of Motor Neuron (SMN) Protein Interacts with the mRNA-Binding Protein HuD and Regulates Localization of Poly(A) mRNA in Primary Motor Neuron Axons
Claudia Fallini et al.
JOURNAL OF NEUROSCIENCE (2011)
TIA1 Prevents Skipping of a Critical Exon Associated with Spinal Muscular Atrophy
Natalia N. Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
INSIGHTS INTO GENOTYPE-PHENOTYPE CORRELATIONS IN SPINAL MUSCULAR ATROPHY: A RETROSPECTIVE STUDY OF 103 PATIENTS
Florence Petit et al.
MUSCLE & NERVE (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
A screen for regulators of survival of motor neuron protein levels
Nina R. Makhortova et al.
NATURE CHEMICAL BIOLOGY (2011)
Axonal Regeneration and Neuronal Function Are Preserved in Motor Neurons Lacking β-Actin In Vivo
Thomas R. Cheever et al.
PLOS ONE (2011)
SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy
John T. Kissel et al.
PLOS ONE (2011)
Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits
Bikem Akten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
Marco A. Passini et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Disruption of the Survival Motor Neuron (SMN) gene in pigs using ssDNA
Monique A. Lorson et al.
TRANSGENIC RESEARCH (2011)
SMN in spinal muscular atrophy and snRNP biogenesis
Tristan H. Coady et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Spinal muscular atrophy: a time for screening
Thomas W. Prior
CURRENT OPINION IN PEDIATRICS (2010)
The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy
Simona Pedrotti et al.
EMBO JOURNAL (2010)
Splicing of the Survival Motor Neuron genes and implications for treatment of SMA
Thomas W. Bebee et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Yimin Hua et al.
GENES & DEVELOPMENT (2010)
Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy
Matthew E. R. Butchbach et al.
HUMAN MOLECULAR GENETICS (2010)
SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy
Markus Riessland et al.
HUMAN MOLECULAR GENETICS (2010)
Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice
Christopher R. Heier et al.
HUMAN MOLECULAR GENETICS (2010)
Cardiac defects contribute to the pathology of spinal muscular atrophy models
Monir Shababi et al.
HUMAN MOLECULAR GENETICS (2010)
Early heart failure in the SMNΔ7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery
Adam K. Bevan et al.
HUMAN MOLECULAR GENETICS (2010)
Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model
Melissa Bowerman et al.
HUMAN MOLECULAR GENETICS (2010)
The heterogeneous nuclear ribonucleoprotein-R is necessary for axonal β-actin mRNA translocation in spinal motor neurons
Michael Glinka et al.
HUMAN MOLECULAR GENETICS (2010)
A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2
Francine M. Jodelka et al.
HUMAN MOLECULAR GENETICS (2010)
CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy
Marco A. Passini et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design
Francesco Danilo Tiziano et al.
JOURNAL OF MEDICAL GENETICS (2010)
Trans-Splicing-Mediated Improvement in a Severe Mouse Model of Spinal Muscular Atrophy
Tristan H. Coady et al.
JOURNAL OF NEUROSCIENCE (2010)
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2010)
Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy
T. -H. Chen et al.
NEUROLOGY (2010)
Spinal Muscular Atrophy: Newborn and Carrier Screening
Thomas W. Prior
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2010)
An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing
Natalia N. Singh et al.
RNA (2010)
Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
Chiara F. Valori et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene
Thomas W. Prior et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA
Virginia B. Mattis et al.
BMC NEUROSCIENCE (2009)
Intron 7 conserved sequence elements regulate the splicing of the SMN genes
Jordan T. Gladman et al.
HUMAN GENETICS (2009)
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy
Ferrill F. Rose et al.
HUMAN MOLECULAR GENETICS (2009)
Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation
Kathrin Meyer et al.
HUMAN MOLECULAR GENETICS (2009)
Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model
Virginia B. Mattis et al.
HUMAN MOLECULAR GENETICS (2009)
Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo
Christopher R. Heier et al.
HUMAN MOLECULAR GENETICS (2009)
Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice
Charlotte J. Sumner et al.
HUMAN MOLECULAR GENETICS (2009)
LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate
Lutz Garbes et al.
HUMAN MOLECULAR GENETICS (2009)
Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy
Travis D. Baughan et al.
HUMAN MOLECULAR GENETICS (2009)
Oligonucleotide-Mediated Survival of Motor Neuron Protein Expression in CNS Improves Phenotype in a Mouse Model of Spinal Muscular Atrophy
Jason H. Williams et al.
JOURNAL OF NEUROSCIENCE (2009)
Regulation of SMN Protein Stability
Barrington G. Burnett et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque et al.
MOLECULAR THERAPY (2009)
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Arthur H. M. Burghes et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy
Kathryn J. Swoboda et al.
PLOS ONE (2009)
Restoration of Full-Length SMN Promoted by Adenoviral Vectors Expressing RNA Antisense Oligonucleotides Embedded in U7 snRNAs
Till Geib et al.
PLOS ONE (2009)
A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy
Natalia N. Singh et al.
RNA BIOLOGY (2009)
Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy
Michelle L. Hastings et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Alternative Splicing Events Are a Late Feature of Pathology in a Mouse Model of Spinal Muscular Atrophy
Dirk Baeumer et al.
PLOS GENETICS (2009)
DcpS as a Therapeutic Target for Spinal Muscular Atrophy
Jasbir Singh et al.
ACS CHEMICAL BIOLOGY (2008)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Sustained Improvement of Spinal Muscular Atrophy Mice Treated with Trichostatin A Plus Nutrition
Heather L. Narver et al.
ANNALS OF NEUROLOGY (2008)
SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing
Zhenxi Zhang et al.
CELL (2008)
Identification and characterization of the porcine (Sus scrofa) survival motor neuron (SMN1) gene:: An animal model for therapeutic studies
Monique A. Lorson et al.
DEVELOPMENTAL DYNAMICS (2008)
Unaffected patients with a homozygous absence of the SMN1 gene
Maria Jedrzejowska et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy
Shingo Kariya et al.
HUMAN MOLECULAR GENETICS (2008)
TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing
Jayarama Krishnan Bose et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy
John Thurmond et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The effect of hydroxyurea in spinal muscular atrophy cells and patients
Wen-Chen Liang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
The RNA Binding Protein hnRNP Q Modulates the Utilization of Exon 7 in the Survival Motor Neuron 2 (SMN2) Gene
Hung-Hsi Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Daily salbutamol in young patients with SMA type II
Marika Pane et al.
NEUROMUSCULAR DISORDERS (2008)
A SMNΔ7 read-through product confers functionality to the SMNΔ7 protein
Virginia B. Mattis et al.
NEUROSCIENCE LETTERS (2008)
Development of a Single Vector System that Enhances Trans-Splicing of SMN2 Transcripts
Tristan H. Coady et al.
PLOS ONE (2008)
Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy
Gabriela E. Oprea et al.
SCIENCE (2008)
Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy
Lyndsay M. Murray et al.
HUMAN MOLECULAR GENETICS (2008)
Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells
C. Angelozzi et al.
JOURNAL OF MEDICAL GENETICS (2008)
hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing
Tsuyoshi Kashima et al.
HUMAN MOLECULAR GENETICS (2007)
Ribonucleoprotein Assembly Defects Correlate with Spinal Muscular Atrophy Severity and Preferentially Affect a Subset of Spliceosomal snRNPs
Francesca Gabanella et al.
PLOS ONE (2007)
Spinal muscular atrophy genetic counseling access and genetic knowledge: Parents' perspectives
Candice Meldrum et al.
JOURNAL OF CHILD NEUROLOGY (2007)
Spinal muscular atrophy:: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence
Julien Marquis et al.
MOLECULAR THERAPY (2007)
Restoration of SMN function:: Delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing
Tristan H. Coady et al.
MOLECULAR THERAPY (2007)
Chaperoning ribonucleoprotein biogenesis in health and disease
Livio Pellizzoni
EMBO REPORTS (2007)
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M. Avila et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Stat5 constitutive activation rescues defects in spinal muscular atrophy
Chen-Hung Ting et al.
HUMAN MOLECULAR GENETICS (2007)
An intronic element contributes to splicing repression in spinal muscular atrophy
Tsuyoshi Kashima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy
E. Mercuri et al.
NEUROLOGY (2007)
Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts
Virginia B. Mattis et al.
HUMAN GENETICS (2006)
Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector
Travis Baughan et al.
MOLECULAR THERAPY (2006)
Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
Katsuya Inagaki et al.
MOLECULAR THERAPY (2006)
In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy
E Hahnen et al.
JOURNAL OF NEUROCHEMISTRY (2006)
In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate
Lars Brichta et al.
ANNALS OF NEUROLOGY (2006)
Valproic acid promotes neurite outgrowth in PC12 cells independent from regulation of the survival of motoneuron protein
J van Bergeijk et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron
NK Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2
L Cartegni et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Spinal muscular atrophy: A deficiency in a ubiquitous protein; a motor neuron-specific disease
UR Monani
NEURON (2005)
Correction of SMN2 pre-mRNA splicing by antisense U7 small nuclear RNAs
C Madocsai et al.
MOLECULAR THERAPY (2005)
The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation
F Gabanella et al.
HUMAN MOLECULAR GENETICS (2005)
Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy
J Jarecki et al.
HUMAN MOLECULAR GENETICS (2005)
A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels
EC Wolstencroft et al.
HUMAN MOLECULAR GENETICS (2005)
The role of histone acetylation in SMN gene expression
LE Kernochan et al.
HUMAN MOLECULAR GENETICS (2005)
SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
TT Le et al.
HUMAN MOLECULAR GENETICS (2005)
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
JD Rothstein et al.
NATURE (2005)
An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy
NN Singh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Axonal defects in mouse models of motoneuron disease
S Jablonka et al.
JOURNAL OF NEUROBIOLOGY (2004)
Modulation of SMN nuclear foci and cytoplasmic localization by its C-terminus
Y Hua et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes
NN Singh et al.
RNA (2004)
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy
C Andreassi et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons
W Rossoll et al.
JOURNAL OF CELL BIOLOGY (2003)
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
L Brichta et al.
HUMAN MOLECULAR GENETICS (2003)
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
T Kashima et al.
NATURE GENETICS (2003)
Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts
LA Skordis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Correction of disease-associated exon skipping by synthetic exon-specific activators
L Cartegni et al.
NATURE STRUCTURAL BIOLOGY (2003)
Splicing double: Insights from the second spliceosome
AA Patel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-β1
Y Hofmann et al.
HUMAN MOLECULAR GENETICS (2002)
Identification of a cis-acting element for the regulation of SMN exon 7 splicing
H Miyajima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model
C Cifuentes-Diaz et al.
HUMAN MOLECULAR GENETICS (2002)
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1
L Cartegni et al.
NATURE GENETICS (2002)
Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
M Feldkötter et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?
W Rossoll et al.
HUMAN MOLECULAR GENETICS (2002)
SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1
PJ Young et al.
HUMAN MOLECULAR GENETICS (2002)
Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2
MD Mailman et al.
GENETICS IN MEDICINE (2002)
Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3′ splice site pairing
SR Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
C Andreassi et al.
HUMAN MOLECULAR GENETICS (2001)
A novel U2 and U11/U12 snRNP protein that associates with the pre-mRNA branch site
CL Will et al.
EMBO JOURNAL (2001)
Treatment of spinal muscular atrophy by sodium butyrate
JG Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Htra2-β1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)
Y Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy
UR Monani et al.
HUMAN MOLECULAR GENETICS (2000)
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
CL Lorson et al.
HUMAN MOLECULAR GENETICS (2000)
分享论文
